Indication
Treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, head and neck cancer.
Loading your page…
Loading your page…
Prostatic Neoplasms;Carcinoma, Non-Small-Cell Lung;Gastrointestinal Neoplasms;Breast Neoplasms;Head and Neck Neoplasms
Marketing Authorisation Holder: Sun Pharmaceutical Industries Europe B.V.
INN: docetaxel
AI Drug & Interaction Analysis
Free account required
Ask Osler about Docetaxel SUN: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.